{"id":332779,"date":"2026-10-29T17:56:29","date_gmt":"2026-10-29T12:26:29","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/thyrocare-technologies-q2-results-fy27-pat-16-crore\/"},"modified":"2026-10-29T17:56:29","modified_gmt":"2026-10-29T12:26:29","slug":"thyrocare-technologies-q2-results-fy27-pat-16-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/thyrocare-technologies-q2-results-fy27-pat-16-crore\/","title":{"rendered":"Thyrocare Technologies Q2 Results FY27: PAT Falls 66.89% to Rs 15.89 Cr, Revenue Rs 270.81 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Thyrocare Technologies Q2 Results FY27 were declared on 29 October 2026, with revenue of Rs 270.81 Cr, up 25.07% YoY from Rs 216.53 Cr. Net profit stood at Rs 15.89 Cr, down 66.89% from Rs 47.99 Cr. These quarterly results for July to September 2026 show YoY growth in revenue but a lower bottom line.<\/p>\n<\/div>\n

Thyrocare Technologies Ltd<\/a> (THYROCARE) Q2 Results FY27 announced on 29 October 2026, covering the company’s financial performance for the July to September quarter. Thyrocare Technologies Q2 Results FY27 show revenue of Rs 270.81 Cr and PAT of Rs 15.89 Cr, each measured against the same quarter a year earlier. The results date also marks the point from which investors can compare the two lines against the prior-year figures.<\/p>\n

This Univest results analysis of Thyrocare Technologies Q2 Results covers the financial highlights, business drivers, outlook and risks behind the numbers. It starts with the Financial Highlights and then moves through each section in turn, using only the figures supplied with the filing.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n